This is a routine periodic disclosure of ongoing share repurchases with no new information. Monitor the next 6-K for continued buyback execution pace, but this filing alone has no trading implications.
Price Chart
Executive Summary
Novo Nordisk filed a routine 6-K disclosing weekly B-share repurchase transactions under its existing DKK 15 billion buyback program. Since the last announcement on July 27, 2026, the company repurchased 1,145,000 B shares for approximately DKK 371 million. The filing is a standard periodic update with no new financial data, guidance, or material events, purely administrative in nature.
Key Facts
- Total buyback program: up to DKK 15 billion over 12 months starting Feb 4, 2026
- Since Feb 4, 2026, Novo repurchased 27,064,179 B shares at avg price DKK 278.35 for total DKK 7.53 billion
- Current treasury shares: 44,249,480 B shares (1.0% of share capital)
- Total shares outstanding: 4,465,000,000 (A and B shares including treasury)
- Weekly transactions (Jul 27–Aug 3): 1,145,000 B shares repurchased for ~DKK 371 million
Financial Impact
Routine buyback update, no material financial impact. Cumulative spend of DKK 7.53 billion against a DKK 15 billion authorization represents ~50% completion with ~6 months remaining.
Risk Factors
- None, this is a routine administrative filing
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 6-K Filing (Primary) | 0001171843-26-005172 |
| Document: 0001171843-26-005172-index-headers.html | 0001171843-26-005172 |
| Document: 0001171843-26-005172-index.html | 0001171843-26-005172 |
| Document: 0001171843-26-005172.txt | 0001171843-26-005172 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 26, 2026 6d ago | 6-K | $39.13 | awaiting T+20 | awaiting T+20 | $40.00 (+2.22%) |
Oct 26, 2026 7d ago | Court Ruling | $38.67 | awaiting T+20 | awaiting T+20 | $40.00 (+3.44%) |
Oct 19, 2026 13d ago | 6-K | $38.42 | awaiting T+20 | awaiting T+20 | $40.00 (+4.11%) |
Oct 13, 2026 20d ago | 6-K | $38.06 | awaiting T+20 | awaiting T+20 | $40.00 (+5.10%) |
Oct 6, 2026 26d ago | 6-K | $37.53 | awaiting T+20 | awaiting T+20 | $40.00 (+6.58%) |
Sep 28, 2026 4w ago | 6-K | $38.71 $38.95 | ▲ +0.61% | ▲ +0.64% | $40.00 (+3.33%) |
Sep 23, 2026 5w ago | Court Ruling | $38.62 $39.43 | ▲ +2.10% | ▲ +2.52% | $40.00 (+3.57%) |
Sep 21, 2026 5w ago | 6-K | $39.80 $38.42 | ▼ −3.47% | ▼ −2.56% | $40.00 (+0.50%) |
Sep 17, 2026 6w ago | 6-K | $43.19 $39.22 | ▼ −9.19% | ▼ −10.40% | $40.00 (−7.39%) |
Sep 15, 2026 6w ago | 6-K | $42.53 $38.06 | ▼ −10.51% | ▼ −13.23% | $40.00 (−5.95%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers